Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV
· Real-Time Price · USD
14.74
-0.20 (-1.34%)
At close: Sep 23, 2025, 3:59 PM
-1.34% (1D)
| Bid | 14.67 |
| Market Cap | 10.07B |
| Revenue (ttm) | 23.23M |
| Net Income (ttm) | -490.63M |
| EPS (ttm) | -1.09 |
| PE Ratio (ttm) | -13.52 |
| Forward PE | -11.76 |
| Analyst | Strong Buy |
| Dividends | n/a |
| Ask | 15.18 |
| Volume | 7,880,866 |
| Avg. Volume (20D) | 6,627,865 |
| Open | 14.95 |
| Previous Close | 14.94 |
| Day's Range | 14.72 - 15.03 |
| 52-Week Range | 8.73 - 16.05 |
| Beta | 1.15 |
| Ex-Dividend Date | n/a |
About ROIV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ROIV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ROIV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsRoivant Sciences Ltd. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+7.76%
Roivant Sciences shares are trading higher after t...
Unlock content with
Pro Subscription
3 months ago
+6.4%
Roivant Sciences shares are trading higher following Q4 reported financial results.
